An evaluation of the relationship between predictors and immune response was conducted using data obtained from a clinical trial in 200 Czech healthy adults aged 24-65 years receiving a booster dose of a monovalent tetanus vaccine in 2017. The response was determined from ELISA antibody concentrations of paired sera obtained before and 4 weeks after the immunisation. While all subjects with initial antibody levels 2.2 IU/ml. The immune response was not affected by sex, age, tetanus vaccine type, concomitant medication, related adverse events or post-vaccination period since there were no significant differences in geometric mean concentrations or seroconversion rates. The seroconversion rate of 56% in smokers was significantly lower than that of 73% achieved in non-smokers. Although the seroconversion rates did not differ between individuals with normal or higher body weight, the adjusted odds ratio (1.3; 95% Cl 1.08-1.60) revealed a positive correlation between seroconversion rate and body mass index (BMI). Although the vaccine-induced response was influenced by pre-vaccination antibody levels, smoking or BMI, the booster immunisation against tetanus produced a sufficient response regardless the predictors.

Alexander Dubček University of Trenčín Faculty of Healthcare Študentská 2 911 50 Trenčín Slovakia

Charles University Prague 3rd Faculty of Medicine Ruská 87 100 00 Prague 10 Czech Republic

Zobrazit více v PubMed

WHO Expert Committee on Biological Standardization (2014) Sixty-third report. Recommendations to assure the quality, safety and efficacy of tetanus vaccines (adsorbed). WHO Technical Report Series No. 980. Available at http://www.who.int/biologicals/vaccines/Tetanus_Recommendations_TRS_980_Annex_5.pdf (Accessed 10 December 2017).

Peduzzi P et al. (1996) A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 49, 1373–1379. PubMed

Borella-Venturini M et al. (2017) Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers. Epidemiology and Infection 145, 1757–1762. PubMed PMC

Simonsen O, Kjeldsen K and Heron I (1984) Immunity against tetanus and effect of revaccination 25–30 years after primary vaccination. The Lancet 2, 1240–1242. PubMed

Simonsen O et al. (1986) The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathologica Et Microbiologica Scandinavica 94, 77–82. PubMed

Simonsen O et al. (1987) Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine 5, 115–122. PubMed

Jones C et al. (2014) The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine 32, 996–1002. PubMed

Niewiesk S (2014) Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Frontiers in Immunology 5, 446. PubMed PMC

Siegrist CA (2003) Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21, 3406–3412. PubMed

Amanna IJ, Carlson NE and Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. The New England Journal of Medicine 357, 1903–1915. PubMed

Younas M et al. (2017) Immune activation, smoking, and vaccine response. AIDS (London, England) 31, 171–173. PubMed

Jafarzadeh A et al. (2012) Lower immunity to tetanus in cigarette smoker subjects. Journal of Occupational Health and Epidemiology 1, 124–131.

Weber DJ et al. (1985) Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. The Journal of the American Medical Association 254, 3187–3189. PubMed

Eliakim A et al. (2006) Reduced tetanus antibody titers in overweight children. Autoimmunity 39, 137–141. PubMed PMC

Sheridan PA et al. (2012) Obesity is associated with impaired immune response to influenza vaccination in humans. International Journal of Obesity 36, 1072–1077. PubMed PMC

Talbot HK et al. (2012) Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine 30, 3937–3943. PubMed PMC

Lim J et al. (2014) The immunogenicity of a single dose of hepatitis A virus vaccines (Havrix(R) and Epaxal(R)) in Korean young adults. Yonsei Medical Journal 55, 126–131. PubMed PMC

Callahan ST et al. (2014) Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. The Journal of Infectious Diseases 210, 1270–1274. PubMed PMC

Gandhi M et al. (2015) The effect of body mass index on post-vaccination maternal and neonatal pertussis antibody levels. Journal of Reproductive Immunology 112, 34–37. PubMed

Sirikun J et al. (2018) Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination. Vaccine 36, 285–291. PubMed

Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults